Ledger.Open graph →
SEC Form D · filed August 18, 2020

Taysha Gene Therapies, Inc

Offering
$96.0M
Sold
$96.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DALLAS, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Elizabeth Zuchelkowski · Detroit, MIDirectorR. A. Session Ii · Dallas, TXExec · DirectorKamran B. Alam · Dallas, TXExecSukumar B. Nagendran · Dallas, TXDirectorSukumar B. Nagendran · Dallas, TXDirectorR. A. Session Ii · Dallas, TXExec · DirectorKamran B. Alam · Dallas, TXExecLaura Witt · PARK CITY, UTDirectorSteve A. Cobb · Carmel, INDirectorSean A. Nolan · Dallas, TXDirectorPaul B. Manning · Dallas, TXDirectorSuyash B. Prasad · Dallas, TXExecTodd Forrest · PARK CITY, UTDirectorSuyash B. Prasad · Dallas, TXExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗